People with blood group O have an increased risk of cerebral venous thrombosis (CVT), or venous stroke, after taking the Oxford-AstraZeneca vaccine, administered as Covishield in India, claimed a large study. Stroke After COVID-19 Vaccine: People With Blood Group O Most at Risk of Stroke After Taking Oxford-AstraZeneca Vaccine, Says Study.
Almost always and without an exception, the results of clinical trials of drugs are published in the most prestigious medical journals, which grossly exaggerate both the safety aspects and benefits of the drugs, Malhotra claimed. "What I am promoting is ethical, evidence-based medical practice and for that, there has to be ethical, evidence-based clinical trials that take into consideration individual patient preferences and values," he said.
Sambalpur: The Covishield booster dose is very effective in increasing the antibodies against Covid-19, a study conducted by doctors of Veer Surendra .
Indian students are increasingly opting for STEM courses, sustainability studies, and the creative industry instead of traditional business courses in the UK, according to Alison Barrett, the British Council s Director for India. The shift is reflected in the British Council s announcement of grants for industry-academia partnerships in STEM and sustainability.